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We present an unusual neurologic emergency in an elderly male patient. Given his presentation and 
risk factors, we presumed the initial symptoms to be secondary to a cerebrovascular accident. As 
the case evolved, however, it became apparent that a more unusual pathology was present. This 
case report showcases a rare condition masquerading as a common neurologic emergency. [West J 
Emerg Med. 2011;12(1):87-89.]
PATIENT PRESENTATION
We present an unusual neurologic emergency. Our patient 
was an 85-year-old retired Portuguese fisherman who 
presented with two days of emesis and one day of diplopia, 
blurry vision and bilateral ptosis. He also complained of 
difficulty managing secretions and dysphagia but denied 
headache, stiff neck, numbness, tingling, extremity weakness 
or difficulty with bowel or bladder control. Past medical 
history included emphysema and osteoarthritis. He did not 
take medications and denied drug allergies. Married for 57 
years, he lived with his wife. He had quit using alcohol and 
tobacco 30 years earlier; prior to that, he had smoked three 
packs a day. He had no recent sick contacts or travel. 
Initial vital signs were as follows: temperature of 98.1°F; 
blood pressure of 163/75mmHg; pulse of 87 beats per minute; 
respiratory rate of 16 breaths per minute; oxygen saturation of 
98% at room temperature. In general, he appeared ill and 
dysarthric. His head and neck exam revealed pooling of 
secretions in the posterior oropharynx, bilateral ptosis. No 
papilledema was noted. He was oriented to person, place and 
time. His pupils were equal, round, reactive to light and 
accommodation. Visual fields were full to confrontation. He 
had limited abduction of both eyes on testing of extraocular 
movements. He was limited in his ability to protrude his 
tongue, although it was midline. Shoulder shrug strength, 
upper extremity strength and lower extremity strength were 
5/5 in the proximal and distal muscle groups. We detected no 
sensory or proprioceptive deficits. Reflexes were 1+ triceps, 
biceps, and brachioradialis bilaterally and 2+ patellar and 
ankle jerks bilaterally. Plantars were downgoing bilaterally. 
Finger-to-nose testing was intact. Gait was not assessed. The 
remainder of the physical exam was unremarkable. 
Laboratory and imaging studies revealed white cell count 
of 10.9, hemoglobin of 16.2, hematocrit of 49.1 and platelets 
of 210. The metabolic panel was unremarkable. Chest 
radiograph showed a possible early right lower lobe infiltrate. 
Computed tomography (CT) of the head revealed extensive 
small vessel disease with old bilateral frontoparietal 
cerebrovascular events. The magnetic resonance imaging 
(MRI), including diffusion-weighted imaging, did not reveal 
any evidence of an acute stroke. Lumbar puncture showed one 
white cell, zero red cells, 31 protein, and 99 glucose. The 
gram stain was negative as was the acid-fast bacilli stain. India 
ink preparation was negative. 
In the emergency department (ED), primary consideration 
was given to patient stability. He was mentating without 
difficulty, had no respiratory distress, and his airway was 
patent. As his radiographic studies were inconclusive, we 
considered additional differential possibilities. Given his age, 
gender and bulbar symptoms, myasthenia gravis figured 
prominently. Serological studies for acetylcholine receptor 
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available. Electromyography showed mild slowing of motor 
and sensory velocities, but these were nonspecific changes. 
We considered edrophonium testing. This drug acts to inhibit 
acetylcholinesterase and will improve symptoms in 
myasthenia gravis by increasing stores of acetylcholine. 
However, because it may cause marked clinical deterioration 
and respiratory failure in conditions other than myasthenia, we 
withheld it, as the patient was stable, and his diagnosis was 
unclear. He was admitted to the hospital ward for further 
testing and observation.
Our patient deteriorated precipitously on the first evening 
of his admission, requiring emergent endotracheal intubation 
for altered mental status and desaturation. He was completely 
paralyzed at the time of intubation without medication and 
was unable to protect his airway, manage secretions, or use the 
muscles of excursion to facilitate breathing. He remained 
immobile on the ventilator, despite an early wean of paralytics 
and sedation. Repeat CT of the head was unchanged. 
Five days after his admission, the patient’s 90-year-old 
wife presented with blurry vision and difficulty swallowing. 
She was directly admitted to the intensive care unit (ICU) for 
observation. At that point, we were certain of botulism, given 
the symptoms in both patients. We contacted the state health 
department, where our request for release of antitoxin from 
storage at the Los Angeles International Airport was approved, 
in cooperation with the Centers for Disease Control (CDC). 
Both patients received the antitoxin the night the wife was 
admitted. Despite the antitoxin, the patient’s wife deteriorated 
clinically and required mechanical intubation. She had two 
episodes of cardiac arrest during her ICU stay; however, she 
was able to be resuscitated and weaned from the ventilator.
We obtained confirmatory testing late in the ICU course. 
Blood sent for a botulinum toxin murine bioassay was positive 
for botulinum toxin A. Stool studies were negative for 
botulinum toxin. Health department staff went to the patient’s 
house and collected home-canned tuna jars and home-canned 
orange juice. The cans were positive for botulinum toxin A.
Approximately two months after discharge from the 
ICU, the husband was dependent on ventilatory support via 
tracheostomy and currently resides in a long-term intensive 
care facility. His wife has regained some strength but has 
developed dementia and now resides in a skilled-nursing 
facility.
DISCUSSION
Botulinum toxin is the most potent biologic toxin known. 
The organism that produces it, Clostridium botulinum, is 
ubiquitous in the soil. Although several routes of poisoning 
exist, including wound botulism, which has seen a new 
emergence in the United States (U.S.) due to intravenous 
heroin use, and infant botulism via ingestion of spores in a 
naïve digestive tract, our discussion here focuses on foodborne 
botulism. Foodborne botulism is caused by the ingestion of 
preformed toxin that has been expressed by organisms 
infecting improperly preserved foods. There are seven distinct 
subtypes, but only A, B, E, and F cause disease in humans. 
The toxin is inactivated by heating at 85°C for five minutes.1 It 
is unlikely that our two elderly patients followed these 
guidelines.
Symptoms begin anywhere from two hours to eight days 
after ingestion of the toxin, with most patients presenting 
within 36 hours. Patients present with a classic descending 
weakness that begins with dysphagia, diplopia and dysarthria. 
Ptosis, gaze paralysis and facial paralysis are often noted. 
Motor paralysis progresses from the upper to the lower limbs. 
In severe poisonings, the diaphragm and intercostals muscles 
can be affected, causing asphyxiation without ventilator 
support. Additional findings can include dry mouth, 
Figure 1. Home canned and processed goods in various stages 
of spoilage.
Figure 2. Canned tuna, undated. Laboratory confirmed positive 
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constipation, and dilated pupils. In foodborne botulism, 
gastrointestinal complaints of nausea and vomiting can 
occasionally occur prior to neurologic findings. Mental status 
is unaffected, as are sensory findings. Fever is uncommon.2
ED care is supportive and may include intubation and, in 
extreme cases, mechanical ventilation. Additional measures 
include early notification of public health officials to facilitate 
antitoxin administration and limit ongoing exposures to other 
potential victims of the contaminated source.
Fewer than 200 cases of all types of botulism are reported 
in the U.S. annually. Of these, usually 10 to 30 outbreaks 
occur each year due to improperly processed foods in the 
home. In the U.S., clinically significant disease is almost 
universally attributed to subtypes A, B and E. The trivalent 
antitoxin contains elements to counteract all of these.3 As of 
March 19, 2010, the CDC has released a heptavalent botulism 
antitoxin under an investigational drug protocol. It is now the 
only antitoxin available in the U.S. for naturally occurring 
non-infant botulism.6
Early administration of antitoxin lends to the most 
favorable outcomes. Botulinum toxin causes a flaccid 
paralysis by blocking release of acetylcholine-containing 
vesicles within the terminal membrane of the motor neuron. 
This binding at the neuromuscular junction is irreversible; 
once the condition has progressed to paralysis, improvement 
will not occur until new motor axons develop to innervate 
paralyzed muscle fibers.2 Antitoxin will stop disease 
progression by preventing the serum toxin from binding but 
will not improve motor function in the affected nerve 
terminals. Once a patient has become ventilator dependent, it 
will take months until clinical resolution. Complications such 
as pneumonia, decubitus ulcers and malnutrition are the rule. 
The botulism antitoxin is a horse-serum derived product, 
so significant allergic reactions are likely to occur; 9% of 
people may have severe reactions.1 For our patients, we were 
fortunate to have an allergist available to assist with skin 
testing prior to antitoxin administration. The antitoxin kit 
includes instructions and doses for skin testing, so this can be 
done without the assistance of a specialist, if necessary. 
Botulism antitoxin is not routinely stocked in EDs by 
expert consensus guidelines; it is only accessible via state 
health departments, whose staffs are able to obtain the 
antitoxin through the CDC. 4 Antitoxin is stocked in strategic 
prepositioned areas throughout the U.S. The exception to this 
is the state of Alaska, where the most common botulism 
poisoning is type E. Trivalent antitoxin is stocked in many 
municipalities where this poisoning is common, due to native 
cultural food practices and processing of whale and seal 
blubbers. Native village health assistants have been trained to 
recognize the classic pentad of botulism, specifically “nausea 
and vomiting, dysphagia, diplopia, dry mouth, and dilated and 
fixed pupils,” and to administer the antitoxin in consultation 
with state health officials.5
The differential diagnosis for acute weakness in the 
elderly is broad, and a detailed review is beyond the scope of 
this article. In this patient population, consideration must be 
given to etiologies as varied as cerebrovascular accidents 
(CVA), intracranial mass lesions, dementia, chronic subdural 
hematomas, depression, adverse drug reactions, thyroid 
derangements and ingestions. Specific causes of descending 
paralysis may include myasthenia gravis, pontine 
cerebrovascular accidents, botulism and Lambert-Eaton 
syndrome. 
These disease processes may be somewhat complicated 
to distinguish. Myasthenia gravis may be confirmed with 
symptom improvement after the administration of an 
acetylcholinesterase inhibitor, such as edrophonium. Brain 
imaging with CT or MRI would likely be abnormal with a 
pontine CVA. In Lambert-Eaton syndrome, patients will show 
an improvement in weakness with repetition of exercise or 
movement. In fact, the Lambert sign, where grip strength 
will increase progressively throughout the duration of a hand 
squeeze, is pathognomic. Botulism can be confirmed with 
toxin assays; however, because the results will be unavailable 
in the ED, a careful history must be obtained should this 
diagnosis be considered.
Address for Correspondence: Cari E. Matthews, MD, Department 
of Emergency Medicine, Naval Medical Center, San Diego, CA. 
Email carielaine@yahoo.com. 
Conflicts of Interest: By the WestJEM article submission agree-
ment, all authors are required to disclose all affiliations, funding 
sources, and financial or management relationships that could 
be perceived as potential sources of bias. The authors disclosed 
none.
REFERENCES
1.  Lawrence DT, Dobmeier SG, Bechtel LK, et al. Food poisoning. 
Emerg Med Clin N Am. 2007; 25:357-373.
2.  Pigott, DC. Foodborne illness. Emerg Med Clin N Am. 2008; 
26:475-497.
3.  Kman NE, Nelson RN. Infectious agents of bioterrorism: a review for 
emergency physicians. Emerg Med Clin N Am. 2008; 26:517-547.
4.  Dart RC, et al. Expert consensus guidelines for stocking of antidotes 
in hospitals that provide emergency care. Ann Emerg Med. 2009; 
54:386-394.
5.  Castrodale, L. Botulism in Alaska. A guide for physicians and 
healthcare providers. 2005 Update. State of Alaska. Department of 
Health and Social Services. Section of Epidemiology.
6.  Investigational Heptavalent Botulinum Antitoxin (HBAT) to replace 
licensed Botulinum antitoxin AB and investigational Botulinum 
antitoxin E. MMWR. Mar 2010; 59(10):299.
Matthews et al.  Contagious Weakness in Elderly Couple